| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 07/08/2004 | WO2004056319A2 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 07/08/2004 | WO2004041755A3 Quinazolinone compounds as calcilytics |
| 07/08/2004 | WO2004041210A3 Antibacterial agents |
| 07/08/2004 | WO2004022060A3 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders |
| 07/08/2004 | WO2004009017A3 Modulators of the glucocorticoid receptor and method |
| 07/08/2004 | WO2004002476B1 Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
| 07/08/2004 | WO2003097598A8 Compound exhibiting pgd 2 receptor antagonism |
| 07/08/2004 | US20040133002 For therapy of disorders including those in which the inhibition of reverse transcriptase is implicated, such as Human Immunodificiency Virus (HIV) and genetically related retroviruses, such as Acquired Immune Deficiency Syndrome (AIDS) |
| 07/08/2004 | US20040132993 Antiviral and antimicrobial guanidine or biguanidine derivatives |
| 07/08/2004 | US20040132800 aminomethyl- or ethyl-substituted indoles, tetrahydrocarbazoles and tetrahydropyrido[1,2-a]indoles |
| 07/08/2004 | US20040132797 treating of or preventing relapse of depression, anxiety disorders, eating disorders, or urinary incontinence |
| 07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2004 | US20040132772 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis |
| 07/08/2004 | US20040132767 1-(m-aryl- or heteroaryl-substituted, e.g., 1-[4-Fluoro-3-(5-fluoropyridin-3-yl)phenyl]-5-methyl-1,5-dihydroimidazo[4,5-c]pyridin-4-one; treatment or prevention of anxiety, convulsions and cognitive disorders |
| 07/08/2004 | US20040132766 1H-imidazo dimers |
| 07/08/2004 | US20040132762 Sulfonamide and sulfamide substituted imidazoquinolines |
| 07/08/2004 | US20040132758 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 07/08/2004 | US20040132757 Triazospiro compounds having nociceptin receptor affinity |
| 07/08/2004 | US20040132744 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications. |
| 07/08/2004 | US20040132735 Beta-carboline derivatives and its pharmaceutical use aginst depression and anxiety |
| 07/08/2004 | US20040132734 Azaindoles having serotonin receptor affinity |
| 07/08/2004 | US20040132733 Novel quinoxalinone derivatives as bradykinin B1 antagonists |
| 07/08/2004 | US20040132732 Quinazolinones and derivatives thereof as factor Xa inhibitors |
| 07/08/2004 | US20040132723 e.g., 9-Ethyl-3-methyl-12-{2-{(1,2,3,4-tetrahydro-1-oxo-5-isoquinolinyl)oxy}ethyl}-9H-imidazo[1,2-d]dipyrido[2,3-b:3',2'-f][1,4]diazepine; potent inhibitors of wild-type (WT) and double mutant strains of HIV-1 RT |
| 07/08/2004 | US20040132716 CGRP antagonists |
| 07/08/2004 | US20040132115 Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity |
| 07/08/2004 | US20040131885 Organic electroluminescent device and organic electroluminescent compound thereof |
| 07/08/2004 | US20040131648 Nuclear hormone receptor compounds, products and methods employing same |
| 07/08/2004 | US20040131545 Anticholesterol agents |
| 07/08/2004 | DE19756881B4 Neue dimere 1,4-Dihydropyridine New dimeric 1,4-dihydropyridines |
| 07/08/2004 | CA2511340A1 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 07/08/2004 | CA2510846A1 New carboxylic acid amides,the preparation thereof and their use as pharmaceutical compositions |
| 07/08/2004 | CA2510376A1 Fungicides based on nitrogen-containing heterocycles |
| 07/08/2004 | CA2510069A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 07/08/2004 | CA2509882A1 Silyl ethers |
| 07/08/2004 | CA2509881A1 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 07/08/2004 | CA2508951A1 Pyridino[2,3-d]pyrimidine derivatives as selective kdr and fgfr inhibitors |
| 07/08/2004 | CA2508658A1 Fungicides |
| 07/08/2004 | CA2507670A1 Naphthyridine derivatives and their use as fungicides |
| 07/07/2004 | EP1435356A1 Quinoline derivatives as CRTH2 antagonists |
| 07/07/2004 | EP1434819A2 Fluorescent pigment composition |
| 07/07/2004 | EP1434773A2 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 07/07/2004 | EP1434604A2 4-haloethenylphenyl tropane:serotonin transporter imaging agents |
| 07/07/2004 | EP1434584A2 Compositions and methods of treatment of cancer |
| 07/07/2004 | EP1434579A1 Imidazole derivatives as antiinflammatory agents |
| 07/07/2004 | EP1434485A1 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
| 07/07/2004 | EP1235827B1 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 07/07/2004 | EP1212321B1 Intermediates for the production of naphthyridine-3-carboxylic acid derivatives |
| 07/07/2004 | EP1047694B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 07/07/2004 | CN1511161A Novel tricyclic dikydro-quinolin derivatives, method for preparing same and pharmaceutical compositions containing same |
| 07/07/2004 | CN1511157A Novel pyrrole derivatives as pharmaceutical agents |
| 07/07/2004 | CN1511155A Amido ether substituted imidazoquinolines |
| 07/07/2004 | CN1511154A Quinuclidines-substituted-multi-cycli-heteroaryls for treatment of disease |
| 07/07/2004 | CN1511151A 3-quinoline-2-(1H)-ylideneindolin-2-one derivatives |
| 07/07/2004 | CN1511042A PD 4 inhibitor and anti-cholinergic agent in combination for treating obstructive airways diseases |
| 07/07/2004 | CN1156476C 1-cycloalkyl-1,8-naphthyridin-4-one derivatives with phosphodiesterase IV inhibitory activity |
| 07/07/2004 | CN1156475C Cynanchun Komarovii extract and its application |
| 07/06/2004 | US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/06/2004 | US6759533 Novel intermediates for the synthesis of certain non-nucleoside reverse transcriptase inhibitors |
| 07/06/2004 | US6759429 Having transforming growth factor- beta inhibitory activity and being useful as fibrosis inhibitors for organs or tissues |
| 07/06/2004 | US6759428 Indole nitriles |
| 07/06/2004 | US6759417 Vascular endothelial growth factor receptor tyrosine kinase inhibitors; such as 7-amino-6-(1h-benzimidazol-2-yl)-3,4-dihydro-5h-imidazo(4,5-b)pyridin-5-one |
| 07/06/2004 | US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 07/06/2004 | CA2312206C Novel bicyclic derivatives of amino-pyrazinones, process for preparing them and pharmaceutical compositions containing them |
| 07/01/2004 | WO2004055163A2 Substituted 1-benzoyl-3-cyano-pyrrolo[1,2-a]quinolines |
| 07/01/2004 | WO2004055019A1 Method of making tricyclic aminocyanopyridine compounds |
| 07/01/2004 | WO2004055016A1 Pyrrolidine and azetidine compounds as ccr5 antagonists |
| 07/01/2004 | WO2004055015A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/01/2004 | WO2004055014A1 Tetracyclic immunomodulatory compounds |
| 07/01/2004 | WO2004055013A1 [1,7]naphthyridines as pde4 inhibitors |
| 07/01/2004 | WO2004055012A1 Indane compounds as ccr5 antagonists |
| 07/01/2004 | WO2004055011A1 Heterocyclic compounds as ccr5 antagonists |
| 07/01/2004 | WO2004055010A2 Cyclopropyl compounds as ccr5 antagonists |
| 07/01/2004 | WO2004055004A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 07/01/2004 | WO2004055003A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 07/01/2004 | WO2004055002A1 Carbazole derivatives and their use as npy-5 antagonists |
| 07/01/2004 | WO2004054584A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists |
| 07/01/2004 | WO2004054581A2 Cyclohexyl compounds as ccr5 antagonists |
| 07/01/2004 | WO2004054507A2 Indolizine compounds |
| 07/01/2004 | WO2004054504A2 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/01/2004 | WO2004039774A3 Mitotic kinesin inhibitors |
| 07/01/2004 | WO2004033426A3 Heteroaryl propyl-piperazines and heteroaryl propyl-piperidines serving as dopaminergic and serotoninergic agents |
| 07/01/2004 | WO2004026819A3 OPIATE ANALOGS SELECTIVE FOR THE delta-OPIOID RECEPTOR |
| 07/01/2004 | WO2004026306A3 Pyrazole derivatives as transforming growth factor (tgf) inhibitors |
| 07/01/2004 | WO2004020439A3 Improved process for preparation of risperidone |
| 07/01/2004 | WO2004018058A3 Compounds, compositions, and methods |
| 07/01/2004 | WO2004016086B1 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 07/01/2004 | WO2004014294A3 4,7-disubstituted indoles and methods of making |
| 07/01/2004 | US20040127714 Method of making tricyclic aminocyanopyridine compounds |
| 07/01/2004 | US20040127711 Process for the direct preparation of 5-alkoxy and 5-acyloxy analogues of campthothecins or mappicene ketones |
| 07/01/2004 | US20040127709 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
| 07/01/2004 | US20040127708 antiviral activities; aids treatment |
| 07/01/2004 | US20040127707 Novel phthalazinones |
| 07/01/2004 | US20040127555 bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; treatment of A beta , IAPP, other amyloids, and alpha -synuclein or NAC fibrillogenesis |
| 07/01/2004 | US20040127528 Metalloproteinase inhibitors |
| 07/01/2004 | US20040127527 Large conductance calcium-activated k channel opener |
| 07/01/2004 | US20040127515 For therapy of hypertension, chronic obstructive pulmonary disease, organ damage, pain, diabetic nephropathy, dementia |
| 07/01/2004 | US20040127514 For therapy of gastroesophageal reflux disease, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome or the like in mammals |
| 07/01/2004 | US20040127508 Substituted pyrazolopyrimidines and thiazolopyrimidines |
| 07/01/2004 | US20040127492 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 |